New drug combination gives hope for acute myeloid leukaemia treatment
March 8, 2017Research and Development acute myeloid leukaemia
A new trial in the US hopes to marry a new pair of drugs as a combination treatment for acute …
Vectura’s COO set to step down
March 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing vectura
Vectura’s Chief Operating Officer, Trevor Phillips, will step down from the board on 25 May before leaving the company on …
FDA and NICE approve of first new hyperparathyroidism drug in 12 years
March 8, 2017Research and Development, Sales and Marketing FDA, NICE, Parsabiv, hyperparathyroidism
The FDA has given the go-ahead for Amgen’s hyperparathyroidism (HPT) therapy Parsabiv (etelcalcetide), marking the first new treatment for patients …
Diabetes drug could be key to treating aggressive breast cancer, research suggests
March 8, 2017Research and Development Cancer, diabetes
Researchers from the Zhejiang University School of Medicine have identified that the function of metabolic enzyme AKR1B1 is key to …
Research gives hope of potential treatment for most deadly paediatric brain tumour
March 8, 2017Research and Development
A study conducted by researchers from Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago has given …
BeiGene to develop $330 million biologics plant
March 7, 2017Manufacturing and Production, Research and Development BeiGene, China, Guangzhou
BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the …
Researchers discover worrying new antibiotic-resistance gene variant
March 7, 2017Manufacturing and Production, Research and Development drug resistance
A new variant of a human gene which is known to cause significant drug resistance in patients has been discovered …
Cadila and Supernus settle patent dispute over epilepsy generic
March 7, 2017Manufacturing and Production, Sales and Marketing Cadila, Supernus, Trokendi XR, Zydus Cadila
A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for …
Merck’s Allergopharma opens €42m biopharmaceutical plant
March 7, 2017Manufacturing and Production Allergopharma, Merck
Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …
Vermont senators call for restraints on “beautiful” pharma advertising
March 6, 2017Manufacturing and Production, Sales and Marketing Bernie Sanders, Vermont, pricing
Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing …
FDA approves first treatment for excessive night-time urination
March 6, 2017Manufacturing and Production FDA, Noctiva, Serenity
The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – …
Negotiating the EU pricing system: How the financial crisis has encouraged closer-knit cooperation between member states
March 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, pricing
Drug pricing is a topic that has become headline-friendly over the past year. It has come to dominate media coverage …
Lilly posts impressive psoriasis results in comparison study
March 6, 2017Research and Development, Sales and Marketing J&J, JJ, Stelara, Taltz, lilly
Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. …
Cipla halts HIV drug production due to delayed government funding
March 6, 2017Sales and Marketing Cipla, HIV, India, Lopinavir
Indian pharmaceutical company Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir (ABT-378) due to the failure by …
UK High Court rules against AbbVie’s Humira patents
March 6, 2017Sales and Marketing AbbVie, Biogen, Fujifilm Kyowa Kirin Biologics, Humira, Samsung Bioepis, biosimilar
The UK High Court has ruled that two of AbbVie patents, related to dosing regimens for rheumatoid arthritis, psoriasis and …
Phase 3 data for Janssen psoriasis drug shows efficacy over Humira
March 6, 2017Research and Development, Sales and Marketing Humira, Janssen, guselkumab, psoriasis
Janssen has revealed new Phase 3 data for its human monoclonal antibody guselkumab in the treatment of adults with moderate …
Otsuka to acquire Neurovance in potential $250 million deal
March 6, 2017Sales and Marketing ADHD, Neurovance, Otsuka Pharmaceuticals
Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal …
Bioverativ adds new member to board of directors
March 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Biogen spinout, Bioverativ, have moved to consolidate its board of directors by appointing Anna Protopapas to the board. Protopapas becomes …
Gene therapy: Advanced treatments for a new era
March 3, 2017Medical Communications gene therapy
Aranca discusses the considerable advances that have occured in the last few years in gene therapy.Considerable research has been conducted …
Top Ten most popular articles on Pharmafile.com this week
March 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
It’s been a busy week on Pharmafile.com over the last seven days. Europe’s first biosimilar treatment for cancer continues to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
